Hematología y Hemoterapia

Resultados: 419
Tipo Título / Nombre Autor(es) Año
Extranodal Natural Killer/T-Cell Lymphoma Nasal Type in 87 Cases from Spain: Clinical Presentation, Treatment and Prognostic Factors. Study from the Geltamo Group González Barca E, Martín A, Bello JL, Bergua Burgués J, Panizo C, Encuentra M, et al 2018
Biomarkers for Predicting Long-Term Disease Control in Transplant-Ineligible Multiple Myeloma Patients: The Presence of an MGUS- like Signature Is the Most Relevant Predictor Rodríguez Otero P, Mateos MV, Martínez López J, Hernández MT, Ocio EM, Rosiñol L, et al 2018
Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Relapsed/Refractory Acute Myeloid Leukemia (AML) Zeidner J, Lin T, Vigil C, Dalovisio A, Wang E, Yair Levy M, et al 2018
Role of Measurable Residual Disease (MRD) in Redefining Complete Response (CR) in Elderly Patients with Acute Myeloid Leukemia (AML): Results from the Pethema-Flugaza Phase III Clinical Trial Paiva B, Martínez Cuadrón D, Bergua Burgués J, Vives S, Lorenzo Algarra J, Tormo M, et al 2018
Precision Medicine Test Is Similar but Faster Than Conventional Cytogenetics Predicting Response in AML Patients and Provides Alternative Treatments Ballesteros J, Martínez Cuadrón D, Martínez López J, Bergua Burgués J, Trmo M, Serrano J, et al 2018
Long-Term Follow up of Front-Line Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide (HiLO trial) for Treatment-Naïve Chronic Lymphocytic Leukemia Felipe Grajales A, Chavez Julio C, Turba EP, Nodzon L, Pérez Leal F, Sandoval Sus J, et al 2018
Long Term Survival Analysis of Multiple Myeloma Patients Receiving Induction Therapy+ Autologous STEM CELL Trasplantation, Comparing Velcade-Dexametasone to Alkylating Polichemotherapy As Induction Therapy Cáceres S, Cardesa R, Cabrera C, Bañas MH, Ibañez F, Prieto J, et al 2018
Characteristics and Outcome of Early T Cell Precursor ALL (ETP-ALL) Patients Treated with High-Risk Spanish Pethema Protocols Genesca E, Morgades M, Montesinos P, Barba P, Gil C, Guàrdia R, et al 2018
Analysis of three salvage treatment regimens after relapsed/refractory acute myeloi leukemia (AML) (FLAG-Ida, FLAGO-IDA and PLERIFLAG) Bergua J, Martínez Cuadrón D, Boluda B, Martínez P, Rodríguez Veiga R, Esteve J, et al 2018
Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role Rodríguez-Otero P, Mateos MV, Martínez-López J, Martín-Calvo N, Hernández MT, Ocio EM, et al 2018